BackJanux Therapeutics Overview

Janux Therapeutics Receivables

Janux Therapeutics's receivables is $35M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$35.00M

Peer average

Loading

Janux Therapeutics Receivables History

Loading

Janux Therapeutics vs. peers: Receivables Comparison

Loading

Janux Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Janux Therapeutics (JANX) FAQ

As of the most recent data (March 2026), JANX shows a receivables of $35M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JANX's receivables is now $35M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Janux Therapeutics is outperforming or lagging.

Tracking JANX's receivables over time shows whether Janux Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $35M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Janux Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $35M) with ownership activity and broader fundamentals.

Janux Therapeutics's receivables is $35M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.